Mental symptoms in Parkinsonian patients treated with L-dopa.
D000368:Aged; D001519:Behavior / Q000187:drug effects; D003863:Depression / Q000139:chemically induced; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects*; D004325:Dreams / Q000187:drug effects; D005260:Female; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008297:Male; D008569:Memory Disorders / Q000139:chemically induced; D001523:Mental Disorders / Q000139:chemically induced* / Q000175:diagnosis; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D011605:Psychoses, Substance-Induced / Q000209:etiology; D012890:Sleep / Q000187:drug effects
D004295:Dihydroxyphenylalanine; D007099:Imipramine